178 related articles for article (PubMed ID: 21542967)
1. Degradation products of different water content sevoflurane in carbon dioxide absorbents by gas chromatography-mass spectrometry analysis.
Li Y; Li YC; Zhang YN; Liu SJ; Zhou YM; Wang CS; Gong YL; Li EY
Chin Med J (Engl); 2011 Apr; 124(7):1050-4. PubMed ID: 21542967
[TBL] [Abstract][Full Text] [Related]
2. Amsorb Plus and Drägersorb Free, two new-generation carbon dioxide absorbents that produce a low compound A concentration while providing sufficient CO2 absorption capacity in simulated sevoflurane anesthesia.
Kobayashi S; Bito H; Morita K; Katoh T; Sato S
J Anesth; 2004; 18(4):277-81. PubMed ID: 15549470
[TBL] [Abstract][Full Text] [Related]
3. Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents.
Struys MM; Bouche MP; Rolly G; Vandevivere YD; Dyzers D; Goeteyn W; Versichelen LF; Van Bocxlaer JF; Mortier EP
Anaesthesia; 2004 Jun; 59(6):584-9. PubMed ID: 15144299
[TBL] [Abstract][Full Text] [Related]
4. Only carbon dioxide absorbents free of both NaOH and KOH do not generate compound A during in vitro closed-system sevoflurane: evaluation of five absorbents.
Versichelen LF; Bouche MP; Rolly G; Van Bocxlaer JF; Struys MM; De Leenheer AP; Mortier EP
Anesthesiology; 2001 Sep; 95(3):750-5. PubMed ID: 11575550
[TBL] [Abstract][Full Text] [Related]
5. Compound A and carbon monoxide production from sevoflurane and seven different types of carbon dioxide absorbent in a patient model.
Keijzer C; Perez RS; de Lange JJ
Acta Anaesthesiol Scand; 2007 Jan; 51(1):31-7. PubMed ID: 17096668
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats.
Stabernack CR; Eger EI; Warnken UH; Förster H; Hanks DK; Ferrell LD
Can J Anaesth; 2003 Mar; 50(3):249-52. PubMed ID: 12620947
[TBL] [Abstract][Full Text] [Related]
7. Compound A concentration is decreased by cooling anaesthetic circuit during low-flow sevoflurane anaesthesia.
Osawa M; Shinomura T
Can J Anaesth; 1998 Dec; 45(12):1215-8. PubMed ID: 10051944
[TBL] [Abstract][Full Text] [Related]
8. Production of compound A under low-flow anesthesia is affected by type of anesthetic machine.
Yamakage M; Kimura A; Chen X; Tsujiguchi N; Kamada Y; Namiki A
Can J Anaesth; 2001 May; 48(5):435-8. PubMed ID: 11394509
[TBL] [Abstract][Full Text] [Related]
9. Compound A concentration in the circle absorber system during low-flow sevoflurane anesthesia: comparison of Drägersorb Free, Amsorb, and Sodasorb II.
Kobayashi S; Bito H; Obata Y; Katoh T; Sato S
J Clin Anesth; 2003 Feb; 15(1):33-7. PubMed ID: 12657409
[TBL] [Abstract][Full Text] [Related]
10. Carbon dioxide absorbents containing potassium hydroxide produce much larger concentrations of compound A from sevoflurane in clinical practice.
Yamakage M; Yamada S; Chen X; Iwasaki S; Tsujiguchi N; Namiki A
Anesth Analg; 2000 Jul; 91(1):220-4. PubMed ID: 10866916
[TBL] [Abstract][Full Text] [Related]
11. Compound A, formaldehyde and methanol concentrations during low-flow sevoflurane anaesthesia: comparison of three carbon dioxide absorbers.
Marini F; Bellugi I; Gambi D; Pacenti M; Dugheri S; Focardi L; Tulli G
Acta Anaesthesiol Scand; 2007 May; 51(5):625-32. PubMed ID: 17430327
[TBL] [Abstract][Full Text] [Related]
12. Performance of four carbon dioxide absorbents in experimental and clinical settings.
Yamakage M; Takahashi K; Takahashi M; Satoh JI; Namiki A
Anaesthesia; 2009 Mar; 64(3):287-92. PubMed ID: 19302642
[TBL] [Abstract][Full Text] [Related]
13. Effects of temperature gradient reduction in three different carbon dioxide absorbents.
Hirabayashi G; Uchino H; Nakajima T; Ogihara Y; Ishii N
Eur J Anaesthesiol; 2009 Jun; 26(6):469-74. PubMed ID: 19307973
[TBL] [Abstract][Full Text] [Related]
14. Compound A production from sevoflurane is not less when KOH-free absorbent is used in a closed-circuit lung model system.
Versichelen L; Bouche MP; Struys M; Van Bocxlaer J; Mortier E; de Leenheer AP; Rolly G
Br J Anaesth; 2001 Mar; 86(3):345-8. PubMed ID: 11573522
[TBL] [Abstract][Full Text] [Related]
15. Quantification of the degradation products of sevoflurane in two CO2 absorbants during low-flow anesthesia in surgical patients.
Frink EJ; Malan TP; Morgan SE; Brown EA; Malcomson M; Brown BR
Anesthesiology; 1992 Dec; 77(6):1064-9. PubMed ID: 1466458
[TBL] [Abstract][Full Text] [Related]
16. Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents. Quantification of degradation products in the circuit.
Bito H; Ikeda K
Anesthesiology; 1994 Aug; 81(2):340-5. PubMed ID: 8053583
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of volatile sevoflurane degradation product formation in an anesthesia circuit by a reduction in soda lime temperature.
Ruzicka JA; Hidalgo JC; Tinker JH; Baker MT
Anesthesiology; 1994 Jul; 81(1):238-44. PubMed ID: 8042791
[TBL] [Abstract][Full Text] [Related]
18. Novel radiator for carbon dioxide absorbents in low-flow anesthesia.
Hirabayashi G; Mitsui T; Kakinuma T; Ogihara Y; Matsumoto S; Isshiki A; Yasuo W
Ann Clin Lab Sci; 2003; 33(3):313-9. PubMed ID: 12956447
[TBL] [Abstract][Full Text] [Related]
19. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans.
Mchaourab A; Arain SR; Ebert TJ
Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591
[TBL] [Abstract][Full Text] [Related]
20. Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A.
Muir WW; Gadawski J
Am J Vet Res; 1998 May; 59(5):603-8. PubMed ID: 9582964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
